OOIR: Observatory of International Research

Papers

(The TQCC of Viruses-Basel is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays	589
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution	437
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention	323
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2	295
A Roadmap for Genome-Based Phage Taxonomy	273
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses	256
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms	240
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner	222
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design	221
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation	183
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters	179
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice	179
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions	173
Comparison of Rapid Antigen Tests for COVID-19	162
Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections	147
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?	145
Dengue: A Minireview	145
In Silico Discovery of Candidate Drugs against Covid-19	143
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection	133
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy	129
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)	127
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?	125
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease	124
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance	123
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2	120

Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?	118
Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic	118
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19	114
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2	114
The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor	113
Mutations and Evolution of the SARS-CoV-2 Spike Protein	112
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	111
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production	110
Curcumin as an Antiviral Agent	108
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA	104
The Advantages and Challenges of Using Endolysins in a Clinical Setting	103
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-	102
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications	102
Herpes zoster: A Review of Clinical Manifestations and Management	101
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses	101
Silencing and Transcriptional Regulation of Endogenous Retroviruses: An Overview	101
Neutralizing Antibody Therapeutics for COVID-19	96
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities	94
Propagation, Inactivation, and Safety Testing of SARS-CoV-2	93
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies	93
Dance with the Devil: Stress Granules and Signaling in Antiviral Responses	90
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs	90
The Spike of Concern—The Novel Variants of SARS-CoV-2	89
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner	88
Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19	88
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies	87
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture	83
Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features	83
West Nile Virus Epidemic in Germany Triggered by Epizootic Emergence, 2019	83
African Swine Fever in Wild Boar in Europe—A Review	82
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations	82
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak	82
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature	81
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues	81
Potential Antiviral Options against SARS-CoV-2 Infection	81
Nipah Virus: Past Outbreaks and Future Containment	81
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives	79
Lentiviral Vector Bioprocessing	77
The Mechanism behind Influenza Virus Cytokine Storm	76
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2	76
Aphid Transmission of Potyvirus: The Largest Plant-Infecting RNA Virus Genus	74
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light	74
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA	73
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP	73
The Interplay between Adeno-Associated Virus and Its Helper Viruses	73
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188	73
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2	72
Antiviral Activity Exerted by Natural Products against Human Viruses	72
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein	72
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals	71

SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations	71
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation	71
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion	70
Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes	70
Persistent Human Papillomavirus Infection	67
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data	66
Viral Vectors for COVID-19 Vaccine Development	66
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics	65
ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever	65
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week	64
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review	64
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence	64
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient	64
Role of Viruses in the Pathogenesis of Multiple Sclerosis	64
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q	63
HIV-1 Maturation: Lessons Learned from Inhibitors	63
Regulation of KSHV Latency and Lytic Reactivation	63
Monkeypox: A Comprehensive Review	63
Recombination in Coronaviruses, with a Focus on SARS-CoV-2	63
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron	62
Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic	62
Host Immune Response Driving SARS-CoV-2 Evolution	62
Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples	62
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2	62
SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study	61
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India	60
LAMP-Coupled CRISPR–Cas12a Module for Rapid and Sensitive Detection of Plant DNA Viruses	60
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse	60
Multifaceted Functions of CH25H and 25HC to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities	59
A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide	58
Block-And-Lock: New Horizons for a Cure for HIV-1	58
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein	57
The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure	57
Clinical Update of Severe Fever with Thrombocytopenia Syndrome	57
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval	57
An Update of Orthopoxvirus Molecular Evolution	57
Current Developments and Challenges in Plant Viral Diagnostics: A Systematic Review	57
Current Trend in Antiviral Therapy for Chronic Hepatitis B	56
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection	55
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2	55
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants	55
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells	55
Jumbo Phages: A Comparative Genomic Overview of Core Functions and Adaptions for Biological Conflicts	55
World-Wide Prevalence and Genotype Distribution of Enteroviruses	54
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland	54
The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV	54
Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland	54
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies	54
The Fatty Acid Lipid Metabolism Nexus in COVID-19	54
Extracellular Vesicles in the Pathogenesis of Viral Infections in Humans	53
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays	53
Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea	53
Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype	53
Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review	53
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1	53
SETDB1-Mediated Silencing of Retroelements	53
Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses	52
Re-Emergence of Yellow Fever in Brazil during 2016–2019: Challenges, Lessons Learned, and Perspectives	52
Dysregulated Interferon Response Underlying Severe COVID-19	52
Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds	52
Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story	52
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review	52
The Spillover of African Swine Fever in Western Poland Revealed Its Estimated Origin on the Basis of O174L, K145R, MGF 505-5R and IGR I73R/I329L Genomic Sequences	51
Stability of African Swine Fever Virus in Carcasses of Domestic Pigs and Wild Boar Experimentally Infected with the ASFV “Estonia 2014” Isolate	51
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)	51
In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic	51
Disease Pandemics and Major Epidemics Arising from New Encounters between Indigenous Viruses and Introduced Crops	50
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients	50
RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients	50
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective	50
Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus	50
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein	50
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment	50
SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa	49
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments	49
Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover	49
Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target	49
HBV-Integration Studies in the Clinic: Role in the Natural History of Infection	49
Multiple Reassortants of H5N8 Clade 2.3.4.4b Highly Pathogenic Avian Influenza Viruses Detected in South Korea during the Winter of 2020–2021	48
Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients	48

Characterization of Potato Virus Y Isolates and Assessment of Nanopore Sequencing to Detect and Genotype Potato Viruses	48
Detection of Highly Pathogenic Avian Influenza Virus H5N1 Clade 2.3.4.4b in Great Skuas: A Species of Conservation Concern in Great Britain	48
HIV Protease: Historical Perspective and Current Research	47
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus	47
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features	47
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro	47
Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments	47
Deletion of CD2-Like (CD2v) and C-Type Lectin-Like (EP153R) Genes from African Swine Fever Virus Georgia-∆9GL Abrogates Its Effectiveness as an Experimental Vaccine	47
Evaluation of the Safety Profile of the ASFV Vaccine Candidate ASFV-G-ΔI177L	47
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development	47
Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy	47
Review of Hepatitis E Virus in Rats: Evident Risk of Species Orthohepevirus C to Human Zoonotic Infection and Disease	46
Identification and Tracking of Antiviral Drug Combinations	46
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives	46
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives	45
Mechanism of Hepatitis B Virus cccDNA Formation	45
A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19	45
Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia	45
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy	45
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines	45
The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature	45
ViralRecall—A Flexible Command-Line Tool for the Detection of Giant Virus Signatures in ‘Omic Data	45
Innate Immune Sensing of Influenza A Virus	45
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection	45
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells	44
Mosquito Vector Competence for Japanese Encephalitis Virus	44
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena	44
Viroplasms: Assembly and Functions of Rotavirus Replication Factories	44
Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios	44
Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil	44
Nosocomial Outbreak of SARS-CoV-2 in a “Non-COVID-19” Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission	43
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity	43
Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality	43
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients	43
Relationships between Viral Load and the Clinical Course of COVID-19	43
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters	43
APOBECs and Herpesviruses	43
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy	43
Viral Shrimp Diseases Listed by the OIE: A Review	43
Extracellular Vesicles in Viral Spread and Antiviral Response	42
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus	42
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis	42
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022	42
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond	42
miRNAs as Potential Biomarkers for Viral Hepatitis B and C	42
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19	42
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines	42
Application of Oxford Nanopore Technology to Plant Virus Detection	42
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs	42
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives	42
Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review	42
Antiviral Drug Discovery for the Treatment of COVID-19 Infections	42
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies	41
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations	41
Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy	41
Human Cytomegalovirus and Autoimmune Diseases: Where Are We?	41
Recent Progress in the Detection of Bacteria Using Bacteriophages: A Review	41
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2	41
Illuminating the Plant Rhabdovirus Landscape through Metatranscriptomics Data	41
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic	40
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations	40
ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection	40
Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding	40
The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats	40
Structures and Functional Diversities of ASFV Proteins	39
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19	39
Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?	39
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins	39
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression	39
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interfero	39
Prevention and Control Strategies of African Swine Fever and Progress on Pig Farm Repopulation in China	39
Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates	39
The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	39
SARS-CoV-2 and Placenta: New Insights and Perspectives	39
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant	39
Deletion of the L7L-L11L Genes Attenuates ASFV and Induces Protection against Homologous Challenge	39
West Nile Virus Mosquito Vectors (Diptera: Culicidae) in Germany	39
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients	38
SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020	38
ACE2-Independent Alternative Receptors for SARS-CoV-2	38
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications	38
Reproduction Number of the Omicron Variant Triples That of the Delta Variant	38
Amantadine Inhibits SARS-CoV-2 In Vitro	38
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?	38
Immunopathology of RSV: An Updated Review	38
Hepatitis B Virus DNA is a Substrate for the cGAS/STING Pathway but is not Sensed in Infected Hepatocytes	38
African Swine Fever Virus (ASFV): Biology, Genomics and Genotypes Circulating in Sub-Saharan Africa	38
SARS-CoV-2: Evolution and Emergence of New Viral Variants	38
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19	38
Re-Invasion of H5N8 High Pathogenicity Avian Influenza Virus Clade 2.3.4.4b in Hokkaido, Japan, 2020	38
Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans	38
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies	38
Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro	38
Hepatitis B Virus-Associated Hepatocellular Carcinoma	38
The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells	37